Biotechnology

The biotech industry comprises bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share of this sector. Advancements in biotechnology has enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Increasing scientific understanding, advanced tools and techniques has led to emergence of various personalized medicines that are now in research phase. According to a research conducted by Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

Biotech sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and also in disease prevention.

Key Challenges

Biotech products have extensive usage in oncology and autoimmune disease treatments. However, the costs of these drugs are exorbitantly high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging, with increased concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which hinders its adoption. Clinical adoption of the biotech products is essential for its success. However, it entails a lot of scientific evidences and explanation to the prescribers in order to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

  • Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to increased demand for the same, with consumers willing to pay high prices for these as compared to other conventional products. Moreover, biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sales of over US$ 2 Bn. Certain drugs such as Humira have generated sales of over US$ 10 Bn. Thus, investing in biotech R&D has yielded better results than pharmaceutical drugs.

For generic players, biosimilars offers a very good growth opportunity, as governments in emerging economies are supporting such therapies as cost-effective alternatives to biotech products. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

  • Erbitux (cetuximab) - February 2016
  • Rituxan (rituximab) - September 2016
  • Herceptin (trastuzumab) - June 2019
  • Avastin (bevacizumab) - July 2019
  • Aranesp (darbepoetin alfa) - May 2024
  • Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz and Amgen are focusing their resources ondevelopment of biosimilars. Also, vaccines are other major products in development to focus on prevention aspect rather than just treatment. For instance, 2015 marked the U.S. launch of Zarxio TM, the first biosimilar approved in this market and the EMA approval of Mosquirix, the malaria vaccine. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

Increasing research in biotech sector, in turn would translate into higher number of biopharma products seeking FDA approvals in future. Biopharma is positioned to be a promising treatment solution that would improve treatment outcomes and serve to accelerate and help reduce cost of drug development.

Coherent Market Insights
Global Tooth Regeneration Market, By Application (Enamel, Dentin, Pulp), Population Demographics (Geriatrics, Middle Aged, Adult), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Tooth Regeneration Global dental industry has undergone a drastic transformation over the last decade. Teeth are among the most important part of human beings, which helps in performing various activities ran

Coherent Market Insights
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical, Nano medicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits Market), and by Region - Global Industry Insights, and Forecast to 2025

Published Date : Apr 2018

Biopharmaceutical and Biomedicine Market - Insights Biopharmaceuticals are drugs that are partially or fully manufactured, or extracted from biological sources. Biopharmaceuticals contain variety of products

Coherent Market Insights
Cell Banking Outsourcing Market, by Type of Bank (Master Cell Banking, Working Cell Banking, and Viral Cell Banking), by Type of Cell (Stem Cell Bank and Non-stem Cell Bank), by Phases of Banking (Cell Bank Storage, Bank Characterization and Testing and Cell Bank Preparation), and by Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Cell banking is a process of replicating and storing cells for the purpose of future use. Storage of these cell samples can be utilized for research purposes and for surgical reconstruction of damaged body structures. Cells are frozen in cryovials at -196 degrees Cels

Coherent Market Insights
Hematopoietic Stem Cell Transplantation (HSCT) Market, by Indication (Leukemia, Lymphatic Disorder, Myeloma, Other Non-malignant Disorders), by Application (Peripheral Blood Cells, Bone Marrow, Umbilical Cord Blood), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 - 2025

To Be Published : May 2018

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in t

Coherent Market Insights
Anti-venom Market, by Anti-venom Type (Polyvalent, Monovalent), by Product Type (Snake Anti-venom, Scorpion Anti-venom, Spider Anti-venom, Other Anti-venom product), by Distribution Channel (Hospitals, Private Clinics, Ambulatory Surgical Centers) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Anti-venom is a medication majorly used to treat snake bites and it can also be used to treat bites from scorpions, spiders or other reptiles. It is made by fractionating the blood of the donor (horse or sheep), which is hyper immunized with snake venom. These product

Coherent Market Insights
Cancer Vaccines Market, By Type (Preventive and Therapeutic), By Technology (Subunit Vaccines, Live Attenuated Vaccines, and Others), and By Application (Cervical Cancer, Prostate Cancer, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. On the basis of the type of cell it initiates to form cancerous with, it is divided into carcinoma, lymphomas, leukaemias

Coherent Market Insights
Shigella Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Shigella is a gram-negative pathogenic enterobacteria that causes severe diarrhea and dysentery in humans. Symptoms associated with Shigella infection includes fever, stomach pain, tenesmus, watery diarrhea, vomiting, dehydration, and convulsions. Various strains of S

Coherent Market Insights
Advanced Therapy Medicinal Products Market - By Product (Somatic Cell Therapy Products, Cell Therapy and Tissue Engineered Products, and Gene Therapy Medicinal Products), By Diseases (Alzheimer’s, Cystic Fibrosis, Muscular Dystrophies, and Hemophilia) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Advanced Therapy Medicinal Products (ATMPs) are innovative therapies that comprises cell therapy, gene therapy, and tissue engineered products. Cell therapy products include cellular immunotherapies and autologous and allogeneic cells for certain therapeutic indicatio

Coherent Market Insights
Biopharmaceutical Contract Manufacturing Market, By Contract Type (Active Pharmaceutical Ingredient (API) and Fill-And-Finished), By Product Type (Interferon, Monoclonal Antibodies, Protein, Vaccines, Vitamins and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexi

Coherent Market Insights
Oral Biologics Market by Therapy Type (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, and Interleukin Inhibitors) by Indications (Arthritis, Asthma, Carcinoma, Crohn’s Disease, Diabetes, Enterocolitis, Multiple myeloma, Multiple sclerosis, Psoriasis, Sarcoma, and Others) By Application (Inflammatory, Metabolic disorders, and Neoplastic) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Oral biologics represent a novel category of drugs, which is gaining traction in the last few decades. Biologic therapeutics has proven to be a highly effective treatment for various chronic ailments, such as diabetes, plaque psoriasis, arthritis, plaque psoriasis, Cr

Coherent Market Insights
Viral Vectors and Plasmid DNA Manufacturing Market - By Product Type (Viral Vectors, Non-Viral Vectors, and Plasmid DNA), By Application (Inherited Disorder, Cancer, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Gene therapy and genetically modified therapies are promising treatment option, which includes introduction of a normal or functional copy of a gene in the defective cell. Gene therapy has capability to cure or prevent the progression of diseases, which include inheri

Coherent Market Insights
Cancer Metabolism Based Therapeutics Market - By Drug (CPI-613 and Enasidenib), By Indication (Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

According to the study published in the Journal of Cancer Biology and Therapy, 2013, the controversial discovery of the 20th century by Otto Warburg led to study of metabolic activity in cancerous tissue, which increases the amount of production of lactate

Coherent Market Insights
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Platelet Rich Fibrin, and Leukocyte-Rich PRF), By Application (Orthopedics, , Neurosurgery, General Surgery, Others) and By Origin (Autologous, Homologus and Allogeneic) - Global Industry Insights, trends, Outlook and opportunity Analysis, 2017 - 2025

To Be Published : May 2018

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma

Coherent Market Insights
Targeted Cancer Therapies Market By Type (Monoclonal Antibodies, Immunotherapy, Antibody Drug Conjugate), and By Application (Breast Cancer, Colorectal Cancer, Lung Cancer) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways fr

Coherent Market Insights
Biobank Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Biobank is a type of repository which collects and store biological samples for biomedical research. The human biological materials include blood, purified DNA, saliva, serum, and other specimens. Preservation of cells and tissues samples is done by cryopreservation a

Coherent Market Insights
Organ Transplant Market, By Organ Type (Kidney, Heart, Lungs, Liver, Intestine, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Organ transplantation is the surgical operation carried out for replacement of damaged or not functional organ of an individual. Donated organ are obtained from living donor, deceased donor or from an animal. Whereas in some cases an artificial organ is used for the t

Coherent Market Insights
Biosimilars Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Biosimilars are biopharmaceutical drug having active components, which are similar to one that has previously been licensed. They are identical copies of the original products and can be manufactured only when the patent for the original innovator product expires. Bio

Coherent Market Insights
Mesenchymal Stem Cells Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Mesenchymal stem cells, also known as Mesenchymal Stromal Cells (MSCs), are adult, fibroblast-like multipotent cells that can differentiate and mature into tissues of mesodermal origin such as adipocytes, chondroblasts, and osteoblasts. Mesenchymal stem cells were iso

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.